These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35286596)

  • 41. Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study.
    Park K; Ahn C; Bang BK; Kang CM; Kim SI; Kim SJ; Kim YS; Kim YS; Koh YB; Kwak JY; Kwon OJ; Moon IS; Moon JI;
    Transplant Proc; 2000 Nov; 32(7):1705-8. PubMed ID: 11119901
    [No Abstract]   [Full Text] [Related]  

  • 42. Red cell exchange transfusion as a rescue therapy for tacrolimus toxicity in a paediatric renal transplant.
    McCarthy H; Inward C; Marriage S; Astley P; Tizard EJ
    Pediatr Nephrol; 2011 Dec; 26(12):2245-8. PubMed ID: 21901503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange.
    Yango A; Morrissey P; Monaco A; Butera J; Gohh RY
    Clin Nephrol; 2002 Jul; 58(1):77-8. PubMed ID: 12141412
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of tacrolimus and mycophenolate mofetil combination on cardiovascular risk profile after kidney transplantation.
    Morales JM; Domínguez-Gil B
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S296-303. PubMed ID: 17130278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
    Wilczek HE; Brattström C; Reinholt FP; Tydén G; Ericzon BG
    Transplant Proc; 1996 Dec; 28(6):3177. PubMed ID: 8962232
    [No Abstract]   [Full Text] [Related]  

  • 46. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H;
    Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract]   [Full Text] [Related]  

  • 47. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity.
    Bentata Y
    Artif Organs; 2020 Feb; 44(2):140-152. PubMed ID: 31386765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Onconephrology in Renal Transplant Patient: A Challenge for the Transplant Nephrologist].
    Sanna E; Manzione AM; Mingozzi S; Biancone L
    G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
    Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
    Marchini F
    G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
    [No Abstract]   [Full Text] [Related]  

  • 51. Delayed Initiation of Tacrolimus Is Safe and Effective in Renal Transplant Recipients With Delayed and Slow Graft Function.
    Liu Y; Liu H; Shen Y; Chen Y; Cheng Y
    Transplant Proc; 2018 Oct; 50(8):2368-2370. PubMed ID: 30316359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acquired Glanzmann's thrombasthenia variant and immune thrombocytopenia in a renal transplant recipient receiving tacrolimus.
    Morath C; Hoffmann T; Kirchhoff EM; Sis J; Zeier M; Scharf RE; Andrassy K
    Thromb Haemost; 2005 Oct; 94(4):879-80. PubMed ID: 16270646
    [No Abstract]   [Full Text] [Related]  

  • 53. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies.
    Graham F; Racicot F; Jamali L; Cong VP; Raboisson MJ; Paradis J; Paradis L; Des Roches A
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):155-7. PubMed ID: 26094803
    [No Abstract]   [Full Text] [Related]  

  • 54. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
    Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
    Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation.
    Becker G; Witzke O; Friedrich J; Albrecht KH; Wagner K; Philipp T; Heemann U
    Transpl Int; 1997; 10(1):51-4. PubMed ID: 9002152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients.
    Kuypers DR
    Clin Pharmacol Ther; 2010 Nov; 88(5):595-6; author reply 597. PubMed ID: 20664539
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of tacrolimus in renal transplantation.
    van Hooff JP; Christiaans MH
    Transplant Proc; 1999 Dec; 31(8):3298-9. PubMed ID: 10616483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tacrolimus for the prevention and treatment of rejection of solid organ transplants.
    Scalea JR; Levi ST; Ally W; Brayman KL
    Expert Rev Clin Immunol; 2016; 12(3):333-42. PubMed ID: 26588770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Chhabra D; Skaro AI; Leventhal JR; Dalal P; Shah G; Wang E; Gallon L
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):504-12. PubMed ID: 22282478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.